Yes, Kevzara Is an Injection
Kevzara (sarilumab) is administered as a subcutaneous injection, typically every two weeks using a pre-filled syringe or auto-injector pen.[1] Patients or caregivers inject it under the skin in areas like the thigh, abdomen, or upper arm.
How Do You Inject Kevzara?
Inject the full 1.14 mL or 1.90 mL dose (depending on body weight and condition) into clean, dry skin. Rotate sites to avoid irritation. Full training from a healthcare provider is required before first use.[1]
What Conditions Does Kevzara Treat?
FDA-approved for moderate-to-severe rheumatoid arthritis in adults who haven't responded well to TNF blockers, and for polyarticular juvenile idiopathic arthritis in children 1 year and older.[1] It's not for other uses like COVID-19 outside trials.
Common Side Effects from Injections
Injection site reactions (redness, itching) affect up to 10% of users. Other risks include infections, high cholesterol, low neutrophils, and liver enzyme elevation. Monitor bloodwork regularly.[1]
How Does It Compare to Other RA Injectables?
Like Humira (adalimumab) or Enbrel (etanercept), Kevzara is self-injected biweekly but targets IL-6 receptors differently from TNF inhibitors. Oral alternatives like Rinvoq exist but have distinct side effect profiles.[1]
Storage and Cost Considerations
Store in the refrigerator at 36-46°F; don't freeze. A 30-day supply costs $4,000-$5,000 without insurance, with patient assistance programs available.[1]
[1]: Kevzara Prescribing Information
[2]: Drugs.com - Kevzara